Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy
Background/AimsSecond-line chemotherapy in patients with advanced pancreatic ductal adenocarcinoma (PDAC) that progresses following gemcitabine-based treatment has not been established. This study aimed to investigate the efficacy and safety of second-line combination chemotherapy with capecitabine...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Gastroenterology Council for Gut and Liver
2017-03-01
|
Series: | Gut and Liver |
Subjects: | |
Online Access: | http://gutnliver.org/journal/view.html?doi=10.5009/gnl16307 |